Approval · Notice of Compliance 597 · 2002
AVONEX: Notice of Compliance 597
Issued August 21, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 597
- Date
- August 21, 2002
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Conversion from single product facility to multi-product facility
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVONEX | Not yet assigned | — |
Medicinal ingredients
- INTERFERON BETA-1A 30 MCG per ML